An approach independent of small molecules to prevent pyroptosis was published by Molina-Crespo et al. where an anti-GSDMB antibody was intracellularly delivered into HER2 positive breast cancer cells, proving that protumour GSDMB functions such as migration, metastasis, and therapy resistance could be reduced [76]. The gene discussed is GSDMB; the disease is breast carcinoma.